Generation of a chemical genetic model for JAK3. (2021)

First Author: Remenyi J
Attributed to:  Development of novel JAK3 inhibitors for the treatment of autoimmunity. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-021-89356-4

PubMed Identifier: 33980892

Publication URI: http://europepmc.org/abstract/MED/33980892

Type: Journal Article/Review

Volume: 11

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322